- Home
- ANL
as 07-26-2024 4:00pm EST
Stocks
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
| Founded: | 2004 | Country: | Cayman Islands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 387.5M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 5.5K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.01 - $19.30 | Next Earning Date: | 08-13-2024 |
| Revenue: | $5,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Adlai Nortye Ltd. News
ANL Breaking Stock News: Dive into ANL Ticker-Specific Updates for Smart Investing
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
Simply Wall St.
2 months ago
Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
Simply Wall St.
2 months ago
Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Compare ANL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANL Adlai Nortye Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.